Therapie der Anämie bei chronisch-entzündlichen Darmerkrankungen

Zusammenfassung

Die Möglichkeiten in der antientzündlichen Stufentherapie, die Substitution von Mangelzuständen und auch die Behandlung von extraintestinalen Begleiterkrankungen bei chronisch- entzündlichen Darmerkrankungen erlauben dem Gastroenterologen eine individuell auf die Bedürfnisse seiner Patienten zugeschnittene Langzeitbetreuung.

Abstract

The development of a stepwise therapy, as detailed below, can be administered to the mostly young patients with Crohn’s disease and ulcerative colitis on an out-patient basis and appropriate to their needs. This is true not only for the activity of the disease, but also for extraintestinal manifestations. The numerous variations in the stepwise anti-inflammatory therapy of chronic inflammatory bowel disease, but also in the substitution therapy of deficiency states and the therapy of accompanying extraintestinal diseases provide the gastroenterologist with the possibility of a long-term treatment tailored to the needs of the individual patient.

Schlüsselwörter

Chronisch-entzündliche Darmerkrankungen - Extraintestinale Manifestationen - Anämie - Intravenöse Eisentherapie - Erythropoietin - Immunsuppressive Therapie

Key words

Inflammatory Bowel Disease - Anaemia - Intravenous Iron Therapy - Erythropoietin - Immunosuppressive Drugs

Literatur

• 1 Stange E F, Schreiber S, Raedler A. et al . Leitlinien der DGVS: Therapie chronisch-entzündlicher Darmerkrankungen. Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterologie. 1997;  35 541-554
• 2 Stange E F, Riemann J, von Herbay A, Lochs H. et al . Diagnostik und Therapie der Colitis ulcerosa: Ergebnisse einer evidenzbasierten Konsensuskonferenz der DGVS.  Z Gastroenterologie. 2001;  39 19-72
• 3 May B. Extraintestinale Manifestationen der chronisch entzündlichen Darmerkrankungen.  Leber Magen Darm. 1997;  29 (Suppl. 3) 17-20
• 4 Gaschè C, Dejaco C, Reinisch W. et al . Sequential Treatment of Anemia in Ulcerative Colitis with Intravenous Iron and Erythropoietin.  Digestion. 1999;  60 262-267
• 5 Gaschè C, Reinisch W, Lochs H. et al . Anemia in Crohn‘s Disease - Importance of Inadequate Erythropoietin Production and Iron Deficiency.  Digestive Diseases and Sciences. 1994;  39 (Nr. 9) 1930-1934
• 6 Gaschè C, Waldhoer T, Feichtenschlager T. et al . Prediction of Response to Iron Sucrose in Inflammatory Bowel Disease-Associated Anemia.  Am Journal of Gastroenterology. 2001;  96 (No. 8) 2382-2387
• 7 Gaschè C. Anemia in IBD: The overlooked Villain.  Inflammatory bowel disease. 2000;  6 142-150
• 8 Mickisch O, Lutz-Vorderbrügge A, Küppers B. Neue Aspekte in der ambulanten Langzeittherapie chronisch-entzündlicher Darmerkrankungen.  Verdauungskrankheiten. 2000;  18 (Nr. 1) 25-32
• 9 Bartels U, Strandberg Pedersen N, Jarnum S. Iron absorption and serum ferritin in chronic inflammatory bowel disease.  Scand J Gastroenterol. 1978;  13 649-656
• 10 Kaplinsky N, Frank O. Salicylazosulphapyridine-induced Heinz Body anemia.  Acta Haematol. 1978;  59 310-314
• 11 Yates P, Macht M, Williams N A, Elson C J. Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anemia.  Br J Haematol. 1992;  82 753-756
• 12 Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys.  Life Sci. 1992;  50 301-308
• 13 Jelkmann W, Fandrey J, Frede S, Pagel H. Inhibition of erythropoietin production by cytokines - Implications for the anemia involved in inflammatory states.  Ann NY Acad Sci. 1994;  718 300-309
• 14 Küppers B, Mickisch O, Lutz-Vorderbrügge A. Erste Erfahrungen mit der ambulanten Erythropoietin-Behandlung eisenrefraktärer Anämien bei chronisch-entzündlichen Darmerkrankungen.  Verdauungskrankheiten. 1999;  17 (Nr. 1) 21-30
• 15 Schreiber S, Howaldt S, Schnoer M. et al . Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.  N Engl J Med. 1996;  334 619-624
• 16 Cartwright G E. The anemia of chronic disorders.  Semin Haematol. 1966;  3 351-375
• 17 Means R T. Advances in the anemia of chronic disease.  Int J Haematol. 1999;  70 7-12
• 18 Schreiber S, Wedel S. Diagnosis and Treatment of anemia in inflammatory bowel disease.  Inflammatory bowel disease. 1997;  3 206-216
• 19 Gaschè C, Dejaco C, Waldhoer T. et al . Intravenous Iron and Erythropoietin for Anemia Associated with Crohn‘s Disease.  Ann Intern Med. 1997;  126 782-787
• 20 Beglinger C, Hess B, Ruchti C. Severe chronic iron deficiency in a 17- year-old student.  Schweiz Rundsch Med Prax. 1998;  87 622-626 (18)
• 21 Rath H C, Caesar I, Roth M, Schölmerich J. Nutritional deficiencies and complications in chronic inflammatory bowel diseases.  Med Klin. 1998;  93 6-10 (1)
• 22 Thomas L. Labor und Diagnose. Marburg; Medizinische Verlagsgesellschaft 1992: 397-407, 649-653
• 23 Danielson B G, Geisser P, Schneider W. Iron Therapy - with Special Emphasis on Intravenous Administration.  Vifor (International) Inc. 1996;  51-60
• 24 Geisser P, Baer M, Schaub E. Structure/Histotoxicity Relationship of Parenteral Iron Preparations.  Arzneim-Forsch/Drug Res. 1992;  43 1439-1452 (II) 1)
• 25 Cullen P, Söffker J, Höpfl M. et al . Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis.  Nephrol Dial Transplant. 1999;  14 659-665
• 26 Schaefer R M, Schaefer L. Hypochromic red blood cells and reticulocytes.  Kidney International. 1999;  55 (Suppl. 69) 44-48
• 27 Hörl W H, Kaltwasser J P, Schäfer R M, Asmus G. Eisen- und rhEPO-Therapie bei Niereninsuffizienz - Stand 1997.  J Pediatr. 1996;  129 258-263
• 28 Schaefer R M. Optimierte Eisengabe bei der chronischen Anämie. Satellitensymposium Erythropoetin Beyond Nephrology Wiesbaden; 11. April 1999
• 29 Heinrich H C. Eisenabsorption oraler FE(II). bzw. FE(III)-Präparate.  Deutsche Apotheker-Zeitschrift. 1996;  14 681-690
• 30 Burns D L, Mascioli E A, Bistrian B R. Parenteral iron dextran therapy: A review.  Nutrition. 1995;  11 163-168
• 31 Höchli P, Wagenhäuser F J, Fehr J. Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis. (Letters to the Editor).  Eur J Haematol. 1993;  51 54-55
• 32 Martini A, Ravelli A, Di Fuccia G. et al . Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis.  Lancet. 1994;  344 1052-1054
• 33 Babbs C F. Oxygen radicals in ulcerative colitis.  Free Radic Biol Med. 1992;  13 169-181 (2)
• 34 Biemond P, Swaak A J, v. Eijk H G, Koster J F. Superoxide dependent iron release from ferritin in inflammatory diseases.  Free Radic Biol Med. 1988;  4 (3) 185-198
• 35 Grisham M B, Granger D N. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites.  Dig Dis Sci. 1988;  33 (3 Suppl.) 6S-15S
• 36 Muntane J, Puig-Parellada P, Mitjavila M T. Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine.  J Lab Clin Med. 1995;  126 435-443 (5)
• 37 Zanen A L, Adriaansen H J, van Bommel E F, Posthuma R, de Jong GM Th. Oversaturation of transferrin after intravenous ferric gluconate (Ferrlecit) in haemodialysis patients.  Nephrol Dial Transplant. 1996;  11 820-824
• 38 Weiss G. Iron and anemia of chronic disease.  Kidney International. 1999;  55 (Suppl. 69) 12-17
• 39 Patruta S, Hörl W H. Iron and infection.  Kidney International. 1999;  55 (Suppl. 69) 125-130
• 40 Macdougall I C. Strategies for iron supplementation: oral versus intravenous.  Kidney Int. 1999;  Suppl. 69 61-66
• 41 Koury M J. Investigating erythropoietin resistance.  N Engl J Med. 1993;  328 205-206
• 42 Ludwig H. et al . Recombinant human erythropoietin for the correction of cancer-associated anemia with and without concomitant cytotoxic chemotherapy.  Cancer. 1995;  76 2319-2329
• 43 Means R T, Krantz S B. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin.  Blood. 1991;  78 2564-2567